p53 mutations and presence of HPV DNA do not correlate with radiosensitivity of gynecological cancer cell lines

Gynecologic Oncology

Volumn 71, Issue 3, 1998, Pages 352-358

  Rantanen, Virpi ^a,d   Grénman, Seija ^a   Kurvinen, Kaisa ^b,c   Hietanen, Sakari ^a,c   Raitanen, Misa ^a   Syrjänen, Stina ^b,c  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Gynecological cancer; Gynecological cancer cell lines; HPV; P53; Radiosensitivity

Indexed keywords

PROTEIN P53; VIRUS DNA;

ARTICLE; CARCINOGENESIS; DNA DETERMINATION; FEMALE; GENE INACTIVATION; GENE MUTATION; GYNECOLOGIC CANCER; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIOSENSITIVITY; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; VIRUS DETECTION; VULVA CARCINOMA; WART VIRUS;

EID: 0032408129     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5194     Document Type: Article

References (48)

1. 1. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304-6311, 1991
2. 2. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB: Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89:7491-7495, 1992
3. 3. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T: p53 status and the efficacy of cancer therapy in vivo. Science 266:807-810, 1994
4. 4. Brachman DG, Beckett M, Graves D, Haraf D, Vokes E, Weichselbaum RR: p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res 53:3667-3669, 1993
5. 5. Lee JM, Bernstein A: p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci USA 90:5742-5746, 1993
6. 6. Zaffaroni N, Benini E, Gornati D, Bearzatto A, Silvestrini R: Lack of correlation between p53 protein expression and radiation response in human tumor primary cultures. Stem Cells 13:77-85, 1995
7. 7. Servomaa K, Kiuru A, Grénman R, Pekkola-Heino K, Pulkkinen JO, Rytömaa T: p53 mutations associated with increased sensitivity to ionizing radiation in human head and neck cancer cell lines. Cell Prolif 29:219-230, 1996
8. 8. O'Connor PM, Jackman J, Jondle D, Bhatia K, Magrath I, Kohn KW: Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res 53:4776-4780, 1993
9. 9. Ribeiro JCC, Barnetson AR, Fisher RJ, Mameghan H, Russell PJ: Relationship between radiation response and p53 status in human bladder cancer cell lines. Int J Radiat Biol 72:11-20, 1997
10. 10. Slichenmyer WJ, Nelson WG, Slebos RJ, Kastan MB: Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Res 53:4164-4168, 1993
11. 11. Weichselbaum RR, Rotmensch J, Ahmed-Swan S, Beckett MA: Radiobiological characterization of 53 human tumor cell lines. Int J Radiat Biol 56:553-560, 1989
12. 12. zur Hausen H: Are human papillomavirus infections not necessary or sufficient causal factors for invasive cancer of the cervix? Int J Cancer 63:315-316, 1995
13. 13. Kurman RJ, Trimble CR, Shah KV: Human papillomavirus and the pathogenesis of vulvar carcinoma. Obstet Gynecol 58:2-5, 1992
14. 14. Kaufman RH: Intraepithelial neoplasia of the vulva. Gynecol Oncol 56: 8-21, 1995
15. 15. Park DJ, Wilczynski SP, Paquette RL, Miller CW, Koeffler HP: p53 mutations in HPV-negative cervical carcinoma. Oncogene 9:205-210, 1994
16. 16. Lee YY, Wilczymski SP, Chumakov A, Chih D, Koeffler HP: Carcinoma of the vulva: HPV and p53 mutations. Oncogene 9:1655-1659, 1994
17. 17. Kohler MF, Berchuck A, Davidoff AM, Humphrey PA, Dodge RK, Iglehart JD, Soper JT, Clarke-Pearson DL, Bast RC, Jr, Marks JR: Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res 52:1622-1627, 1992
18. 18. Berchuck A, Kohler MF, Marks JR, Wiseman R, Boyd J, Bast RCJ: The p53 tumor suppressor gene frequently is altered in gynecologic cancers. Am J Obstet Gynecol 170:246-252, 1994
19. 19. Rantanen V, Grénman S, Kulmala J, Alanen K, Lakkala T, Grénman R: Sublethal damage repair after fractionated irradiation in endometrial cancer cell lines tested with the 96-well plate clonogenic assay. J Cancer Res Clin Oncol 120:712-716, 1994
20. 20. Rantanen V, Grénman S, Kulmala J, Grénman R: The intrinsic radiosensitivity and sublethal damage repair capacity of five cervical carcinoma cell lines tested with the 96-well-plate assay. J Cancer Res Clin Oncol 121:230-234, 1995
21. 21. Rantanen V, Grénman S, Kulmala J, Salmi T, Grénman R: Radiation sensitivity of endometrial carcinoma in vitro. Gynecol Oncol 44:217-222, 1992
22. 22. Rantanen V, Grénman S, Kulmala J, Jaakkola M, Lakkala T, Sajantila A, Klemi P, Grénman R: Characterization and radiosensitivity of UT-EC-2A and UT-EC-2B, two new highly radiosensitive endometrial cancer cell lines derived from a primary and metastatic tumor of the same patient. Gynecol Oncol 56:53-62, 1995
23. 23. Jaakkola M, Rantanen V, Grénman S, Kulmala J, Grénman R: In vitro concurrent paclitaxel and radiation of four vulvar squamous cell carcinoma cell lines. Cancer 77:1940-1946, 1996
24. 24. Grénman SE, Worsham MJ, Van Dyke DL, England B, McClatchey KD, Hopkins M, Babu VR, Grénman R, Carey TE: Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new ER-negative vulvar carcinoma cell lines, UM-SCV-1A and UM-SCV-1B. Int J Cancer 45:920-927, 1990
25. 25. Worsham MJ, Van Dyke DL, Grénman SE, Grénman R, Hopkins MP, Roberts JA, Gasser KM, Schwartz DR, Carey TE: Consistent chromosome abnormalities in squamous cell carcinoma of the vulva. Genes Chromosomes Cancer 3:420-432, 1991
26. 26. Jaakkola M, Rantanen V, Grénman S, Kulmala J, Grénman R: Vulvar squamous cell carcinoma cell lines are sensitive to paclitaxel in vitro. Anticancer Res 17:939-944, 1997
27. 27. Grénman R, Burk D, Virolainen E, Buick RN, Church J, Schwartz DR, Carey TE: Clonogenic cell assay for anchorage-dependent squamous carcinoma cell lines using limiting dilution. Int J Cancer 44:131-136, 1989
28. 28. Miller SA, Dykes DD, Polensky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:73-84, 1988
29. 29. Buchman VL, Chumakov PM, Ninkina NN, Samarina OP, Georgiev GP: A variation in the structure of the protein-coding region of the human p53 gene. Gene 70:245-252, 1988
30. 30. Kurvinen K, Hietanen S, Syrjánen K, Syrjänen S: Rapid and effective detection of mutations in the p53 gene using nonradioactive single-strand conformation polymorphism (SSCP) technique applied on PhastSystem. J Virol Methods 51:43-54, 1995
31. 31. Manos MM, Ting Y, Wright DK, Lewis A, Broker TR, Wolinsky SM: Use of polymerase chain reaction amplification for the detection of genital papillomaviruses. Cancer Cells 7:209-214, 1989
32. 32. Hietanen SH, Kurvinen K, Syrjänen K, Grénman S, Carey T, McClatchey K, Syrjänen S: Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells. Am J Obstet Gynecol 173:1477-1482, 1995
33. 33. Yaginuma Y, Westphal H: Analysis of the p53 gene in human uterine carcinoma cell lines. Cancer Res 51:6506-6509, 1991
34. 34. Hietanen S, Grénman S, Syrjänen K, Lappalainen K, Kauppinen J, Carey T, Syrjänen S: Human papillomavirus in vulvar and vaginal carcinoma cell lines. Br J Cancer 72:134-139, 1995
35. 35. Kawashima K, Mihara K, Usuki H, Shimizu N, Namba M: Transfected mutant p53 gene increases X-ray-induced cell killing and mutation in human fibroblasts immortalized with 4-nitroquinoline 1-oxide but does not induce neoplastic transformation of the cells. Int J Cancer 61:76-79, 1995
36. 36. Biard DSF, Martin M, Rhun YL, Duthu A, Lefaix JL, May E, May P: Concomitant p53 gene mutation and increased radiosensitivity in rat lung embryo epithelial cells during neoplastic development. Cancer Res 54: 3361-3364, 1994
37. 37. Werness BA, Levine AJ, Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79, 1990
38. 38. Kupelian PA, Eifel PJ, Tornos C, Burke TW, Delclos L, Oswald MJ: Treatment of endometrial carcinoma with radiation therapy alone. Int J Radiat Oncol Biol Phys 27:817-824, 1993
39. 39. Rose PG, Baker S, Kern M, Fitzgerald TJ, Tak WK, Reale FR, Nelson BE, Hunter RE: Primary radiation therapy for endometrial carcinoma: a case controlled study. Int J Radiat Oncol Biol Phys 27:585-590, 1993
40. 40. Rouanet P, Dubois JB, Gely S, Pourquier H: Exclusive radiation therapy in endometrial carcinoma. Int J Radiat Oncol Biol Phys 26:223-228, 1993
41. 41. Deacon J, Peckham MJ, Steel GG: The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol 2:317-323, 1984
42. 42. Fertil B, Malaise EP: Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. Int J Radiat Oncol Biol Phys 11:1699-1707, 1985
43. 43. Casey G, Lopez ME, Ramos JC, Plummer SJ, Arboleda MJ, Shaughnessy M, Karlan B, Slamon DJ: DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies. Oncogene 13:1971-1981, 1996
44. 44. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253:49-53, 1991
45. 45. Fujita M, Inoue M, Tanizawa O, Iwamoto S, Enomoto T: Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res 52:5323-5328, 1992
46. 46. Kim JW, Lee CG, Han SM, Kim KS, Kim JO, Lee JM, Kim IK, Namkoong SE: Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection. Gynecol Oncol 67:215-221, 1997
47. 47. Butz K, Shahabeddin L, Geisen C, Spitkovsky D, Ullman A, Hoppe-Seyler F: Functional p53 protein in human papillomavirus-positive cancer cells. Oncogene 10:927-936, 1995
48. 48. Yu Y, Li C-Y, Little JB: Abrogation of p53 function by HPV16 E6 gene delays apoptosis and enhances mutagenesis but does not alter radiosensitivity in TK6 human lymphoblast cells. Oncogene 14:1661-1667, 1997